Our results suggest that TRPM8 and TRPM8-mediated membrane depolarization, but not TRPA1 or TRPV1, serve as the initial ionic/membrane drives that contribute to the development of oxaliplatin-induced neuropathic pain. This evidence concerns the gene TRPV1 and neuropathic pain.